Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking
Lihong Liu, Ryan G. Casner, Yicheng Guo, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2442-2455.e8
Open Access | Times Cited: 16

Showing 16 citing articles:

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86
Daming Zhou, Piyada Supasa, Chang Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
A generalized framework to identify SARS-CoV-2 broadly neutralizing antibodies
Fanchong Jian, Anna Z. Wec, Leilei Feng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
Arman Izadi, Pontus Nordenfelt
Trends in Immunology (2024) Vol. 45, Iss. 8, pp. 609-624
Open Access | Times Cited: 6
Recurrent SARS-CoV-2 spike mutations confer growth advantages to select JN.1 sublineages
Qian Wang, Ian A. Mellis, Anthony Bowen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern
Adonis A. Rubio, Viren A. Baharani, Bernadeta Dadonaite, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 788
Closed Access
Evolving spike-proteinN-glycosylation in SARS-CoV-2 variants
Sabyasachi Baboo, Jolene K. Diedrich, Jonathan L. Torres, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants
Gang Ye, Fan Bu, Ruangang Pan, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012493-e1012493
Open Access | Times Cited: 3
Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
Xiaofeng Niu, Zhiqiang Li, Jing Wang, et al.
Emerging Microbes & Infections (2024)
Open Access | Times Cited: 2
Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
Craig Fenwick, Priscilla Turelli, Yoan Duhoo, et al.
Journal of Infection (2023) Vol. 87, Iss. 6, pp. 524-537
Open Access | Times Cited: 5
Epitope mapping via in vitro deep mutational scanning methods and its applications
Meredith M. Keen, A. Keith, Eric A. Ortlund
Journal of Biological Chemistry (2024), pp. 108072-108072
Open Access | Times Cited: 1
Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern
Adonis A. Rubio, Viren A. Baharani, Bernadeta Dadonaite, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Understanding the Molecular Actions of Spike Glycoprotein in SARS-CoV-2 and Issues of a Novel Therapeutic Strategy for the COVID-19 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
BioMedInformatics (2024) Vol. 4, Iss. 2, pp. 1531-1555
Open Access
Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain
Xiaofeng Niu, Zhiqiang Li, Jing Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages
Melanie R. Walker, Alexander P. Underwood, Kasper H. Björnsson, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access
Monoclonal antibodies lock down SARS-CoV-2 spike
Hsiang‐Chi Huang, Davide Angeletti
Trends in Immunology (2023) Vol. 44, Iss. 11, pp. 874-876
Open Access
Page 1

Scroll to top